Name:	ifrs-full_DisclosureOfContingentLiabilitiesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2024-01-01
-Paragraph 40
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_b&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to CRT.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToCRT
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to diaprost AB.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToDiaprostAB
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to nanomab.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToNanoMab
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to neo indicate LLC.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToNeoIndicateLLC
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to Pharma15.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToPharma15
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to radiopharm ventures LLC.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToRadiopharmVenturesLLC
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment for development milestone to TRIMT.

No definition available.

Name:	radx_PaymentForDevelopmentMilestoneToTRIMT
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with CRT.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithCRT
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with Diaprost AB.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithDiaprostAB
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with nanomab technology limited.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithNanoMabTechnologyLTD
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with NeoIndicate LLC.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithNeoIndicateLLC
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with pharma15.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithPharma15
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment of license agreement with TRIMT.

No definition available.

Name:	radx_PaymentOfLicenseAgreementWithTRIMT
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payments for milestones.

No definition available.

Name:	radx_PaymentsForMilestones
Namespace Prefix:	radx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_AVb6IntegrinIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_huPSAAntibodyIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_NanoMabIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_Pharma15Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_PivalateIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_NeoIndicateIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_IntangibleAssetsMaterialToEntityAxis=radx_RadiopharmVenturesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=radx_FirstPatientDosedInTheFirstPhaseOneTherapeuticClinicalTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: